Cyril H Benes Selected Research

Cyril H Benes Research Topics

Disease

75	Neoplasms (Cancer) 04/2024 - 07/2011
16	Lung Neoplasms (Lung Cancer) 04/2024 - 09/2011
8	Breast Neoplasms (Breast Cancer) 04/2024 - 12/2013
8	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2023 - 03/2013
6	Neuroblastoma 01/2022 - 01/2015
6	Ewing Sarcoma (Sarcoma, Ewing) 10/2021 - 03/2012
4	Pancreatic Neoplasms (Pancreatic Cancer) 01/2022 - 01/2015
4	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 01/2021 - 01/2018
4	Hypersensitivity (Allergy) 01/2019 - 01/2015
3	Cholangiocarcinoma 01/2022 - 01/2016
3	Hematologic Neoplasms (Hematological Malignancy) 01/2018 - 01/2017
3	Melanoma (Melanoma, Malignant) 10/2017 - 01/2015
2	Multiple Myeloma 04/2024 - 01/2018
2	Liver Neoplasms (Liver Cancer) 01/2023 - 10/2017
2	Carcinogenesis 10/2021 - 01/2018
2	Neoplasm Metastasis (Metastasis) 10/2021 - 02/2013
2	B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia) 01/2021 - 01/2018
2	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 01/2019 - 01/2018
2	Adenocarcinoma 01/2019 - 07/2014
2	Colorectal Neoplasms (Colorectal Cancer) 01/2017 - 01/2014
2	Disease Progression 10/2016 - 11/2014
2	Oncogene Addiction 03/2012 - 09/2011
1	Triple Negative Breast Neoplasms 11/2022
1	Colonic Neoplasms (Colon Cancer) 01/2022
1	Squamous Cell Carcinoma of Head and Neck 01/2022
1	Head and Neck Neoplasms (Head and Neck Cancer) 12/2021
1	Precursor T-Cell Lymphoblastic Leukemia-Lymphoma (T-ALL) 01/2019

Drug/Important Bio-Agent (IBA)

13	Proteins (Proteins, Gene)FDA Link 01/2021 - 02/2013
12	Biomarkers (Surrogate Marker)IBA 01/2022 - 03/2012
9	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 01/2022 - 01/2013
9	Poly(ADP-ribose) Polymerase InhibitorsIBA 01/2019 - 03/2012
6	Phosphotransferases (Kinase)IBA 01/2022 - 09/2011
6	venetoclaxIBA 01/2021 - 02/2016
6	RNA (Ribonucleic Acid)IBA 01/2019 - 09/2011
5	Drug CombinationsIBA 01/2023 - 12/2014
5	ErbB Receptors (EGF Receptor)IBA 12/2021 - 10/2013
5	DNA (Deoxyribonucleic Acid)IBA 04/2019 - 03/2013
4	ChromatinIBA 04/2019 - 05/2014
4	olaparibIBA 01/2019 - 10/2013
4	TIC10 compoundIBA 01/2018 - 01/2017
3	Tyrosine Kinase InhibitorsIBA 04/2024 - 12/2014
3	Mitogen-Activated Protein KinasesIBA 01/2022 - 01/2017
3	Adenosine Triphosphate (ATP)IBA 01/2021 - 01/2018
3	Mechanistic Target of Rapamycin Complex 1IBA 11/2020 - 01/2014
3	lorlatinibIBA 01/2020 - 01/2018
3	ONC212IBA 12/2019 - 10/2017
3	navitoclaxIBA 01/2019 - 03/2015
3	Poly(ADP-ribose) Polymerases (Poly ADP Ribose Polymerase)IBA 01/2018 - 03/2012
3	Small Interfering RNA (siRNA)IBA 01/2018 - 01/2013
3	Anaplastic Lymphoma KinaseIBA 01/2018 - 12/2014
2	Irinotecan (Camptosar)FDA LinkGeneric 01/2022 - 10/2017
2	SHP099IBA 01/2022 - 01/2022
2	EWS-FLI fusion proteinIBA 10/2021 - 01/2019
2	GSK-J4IBA 10/2021 - 01/2018
2	Erlotinib Hydrochloride (CP 358,774)FDA Link 01/2020 - 05/2014
2	1,2- di- (4- sulfamidophenyl)- 4- butylpyrazolidine- 3,5- dione (DSB)IBA 04/2019 - 01/2015
2	Fibroblast Growth Factor Receptors (Fibroblast Growth Factor Receptor)IBA 01/2019 - 12/2014
2	STAT3 Transcription Factor (Signal Transducer and Activator of Transcription 3)IBA 01/2019 - 07/2011
2	Transcription Factors (Transcription Factor)IBA 12/2018 - 01/2018
2	Lysine (L-Lysine)FDA Link 01/2018 - 03/2015
2	Complement System Proteins (Complement)IBA 12/2017 - 10/2015
2	CrizotinibIBA 10/2017 - 10/2016
2	Cisplatin (Platino)FDA LinkGeneric 10/2013 - 03/2013
2	Tyrosine (L-Tyrosine)FDA Link 02/2013 - 07/2011
1	Alkylating AgentsIBA 01/2023
1	UbiquitinIBA 11/2022
1	EnzymesIBA 11/2022
1	TAK-243IBA 11/2022
1	tyrosine receptor (receptor, tyrosine)IBA 01/2022
1	EpiregulinIBA 01/2022
1	Focal Adhesion Protein-Tyrosine KinasesIBA 12/2021
1	RNA Polymerase II (RNA Polymerase B)IBA 10/2021
1	DNA-Directed RNA Polymerases (RNA Polymerase)IBA 10/2021
1	AZD3965IBA 01/2021
1	NVP-CGM097IBA 01/2021
1	Topotecan (Hycamtin)FDA LinkGeneric 01/2021
1	Monocarboxylic Acid TransportersIBA 01/2021
1	S63845IBA 01/2021
1	AlginatesIBA 01/2021
1	Phenformin (Fenformin)IBA 01/2021
1	Cyclophosphamide (Cytoxan)FDA LinkGeneric 01/2021
1	Vacuolar Proton-Translocating ATPases (V-Type ATPase)IBA 11/2020
1	verucopeptinIBA 11/2020
1	Adenosine Triphosphatases (ATPase)IBA 11/2020
1	Nucleic AcidsIBA 01/2020
1	Estrogen Receptor Modulators (Antiestrogen)IBA 01/2020
1	Protein-Tyrosine Kinases (Tyrosine Kinase)IBA 01/2020
1	G-Protein-Coupled Receptors (Receptors, G Protein Coupled)IBA 12/2019
1	MTOR InhibitorsIBA 01/2019
1	infigratinibIBA 01/2019
1	Type 1 Fibroblast Growth Factor Receptor (Fibroblast Growth Factor Receptor 1)IBA 01/2019
1	futibatinibIBA 01/2019
1	CH5183284IBA 01/2019
1	Proto-Oncogene Proteins c-bcl-2 (Proto Oncogene Proteins c bcl 2)IBA 12/2018
1	Paclitaxel (Taxol)FDA LinkGeneric 10/2018
1	MicroRNAs (MicroRNA)IBA 01/2018
1	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2018

Therapy/Procedure

37	Therapeutics 04/2024 - 03/2012
8	Drug Therapy (Chemotherapy) 12/2021 - 09/2011
1	Aftercare (After-Treatment) 01/2020